Sawgrass Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.3M Sell
26,355
-106
-0.4% -$54.8K 1.89% 13
2026
Q2
$14.3M Buy
26,461
+1,352
+5% +$761K 1.89% 14
2026
Q1
$14.9M Sell
25,109
-744
-3% -$371K 2.24% 8
2025
Q4
$12.6M Sell
25,853
-1,484
-5% -$691K 1.57% 14
2025
Q3
$11.5M Buy
+27,337
New +$9.19M 1.42% 17

Other funds holding UTHR

Sawgrass Asset Management's UTHR Position: Q3 2026 in Review

Sawgrass Asset Management reduced its United Therapeutics (UTHR) stake by 0.4% in Q3 2026, selling an estimated $54.8K and leaving 26,355 shares worth $14.3M. The position accounts for 1.89% of the portfolio, ranked #13.

Sawgrass Asset Management first reported a position in UTHR in Q3 2025 and has held it in 5 quarters since. The position peaked at $14.9M in Q1 2026. 841 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Sawgrass Asset Management held 26,355 shares of United Therapeutics worth $14.3M as of Q3 2026.
  • Sawgrass Asset Management sold 106 United Therapeutics shares in Q3 2026, an estimated $54.8K.
  • United Therapeutics made up 1.89% of Sawgrass Asset Management's portfolio in Q3 2026, its #13 holding.
  • Sawgrass Asset Management first reported a position in United Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Sawgrass Asset Management's United Therapeutics position peaked at $14.9M in Q1 2026.
  • 841 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Sawgrass Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.